ArticleClinical hypertension2025
Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.
Jinho Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.